Abstract:Background: The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) is termed overlap syndrome (OS). COPD and OSA both have increased risks of developing cardiovascular diseases. This study aimed to explore if patients with OS exhibited a higher prevalence of cardiovascular complications, and if patients with OS exhibited vascular endothelial dysfunction and abnormalities in the cellular immune function of T lymphocytes. Methods: Totally 25 patients with stable COPD (COPD group), 25 patients with OSA (OSA group), 25 patients with OS (OS group), and 20 healthy adults (control group) were enrolled between January 2017 and December 2017 from the Respiratory Department of Tianjin Medical University General Hospital. The clinical characteristics of the four groups were collected and the expression levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), tumor necrosis factor-alpha (TNF-alpha), and T-lymphocyte subsets were detected. One-way analysis of variance, chi(2) test and Pearson correlation were used to manage the data. Results: The prevalence of hypertension and coronary heart disease was significantly higher in the OS group than in the control, OSA, and COPD groups (chi(2) = 20.69, P < 0.05 and chi(2) = 11.03, P < 0.05, respectively). The levels of sVCAM-1 and TNF-alpha were significantly higher in the OS group than in other groups (F = 127.40, P < 0.05 and F = 846.77, P < 0.05, respectively). The percentage of CD4(+) lymphocytes and CD4(+)/CD8(+) were both significantly lower in the OS group than in any other group (F = 25.40, P < 0.05 and F = 75.08, P < 0.05, respectively). There were significantly negative correlations in the levels of sVCAM-1 and TNF-alpha with CD4(+)/CD8(+) lymphocytes (r = -0.77, P < 0.05 and r = -0.83, P < 0.05, respectively). Conclusions: The prevalence of hypertension and coronary heart disease was higher in patients with OS than in patients with either OSA or COPD alone. Patients with OS exhibited more severe vascular endothelial injury, stronger inflammatory response, and lower cellular immune function.

Association of Toll like receptors and obstructive sleep apnea hypopnea sy ndrome

Research Progress of the Role of T Lymphocytes in Obstructive Sleep Apnea Syndrome-Related Atherosclerosis

The innate immune toll-like-receptor-2 modulates the depressogenic and anorexiolytic neuroinflammatory response in obstructive sleep apnoea

Toll-like receptors in inflammation, infection and cancer

Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS)

Obstructive sleep apnea-hypopnea syndrome immunological relationship

[Role and Mechanism of Th17/Treg in Obstructive Sleep Apnea Hypopnea Syndrome].

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease

The Role of Toll-like Receptors in Periodontitis.

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

The association of lymphocyte with hypothyroidism in obstructive sleep apnea

Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

From Molecular Mechanisms to Clinical Applications

The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome.

Development of the Research on the Inflammatory Factors Related to Obstructive Sleep Apnea Hypopnea Syndrome and Therapy

Endothelial Function and T-lymphocyte Subsets in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea

Association Between Obstructive Sleep Apnea and Cardiovascular Diseases.

Toll-like receptors and their relations with ocular surface diseases

Toll-like receptor 4: A potential therapeutic target for multiple human diseases

CD4 + T-lymphocyte subsets in nonobese children with obstructive sleep apnea syndrome